Liu Jing-Lan, Chen Fen-Fen, Chang Shun-Fu, Chen Cheng-Nan, Lung Jrhau, Lo Cheng-Hsing, Lee Fang-Hui, Lu Ying-Chou, Hung Chien-Hui
Department of Pathology, Chang Gung Memorial Hospital Chiayi Branch, Chiayi, Taiwan; Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Department of Pathology, Chang Gung Memorial Hospital Chiayi Branch, Chiayi, Taiwan.
PLoS One. 2015 Oct 27;10(10):e0141308. doi: 10.1371/journal.pone.0141308. eCollection 2015.
Beclin 1 and Beclin 2 are autophagy-related proteins that show similar amino acid sequences and domain structures. Beclin 1 established the first connection between autophagy and cancer. However, the role of Beclin 2 in cancer is unclear. The aims of this study were to analyze Beclin 1 and Beclin 2 expressions in oral cancer tissues and in cell lines, and to evaluate their possible roles in cancer progression.
We investigated Beclin 1 and Beclin 2 expressions by immunohistochemistry in 195 cases of oral cancer. The prognostic roles of Beclin 1 and Beclin 2 were analyzed statistically. In vitro, overexpression and knockdown of Beclin proteins were performed on an oral cancer cell line, SAS. The immunofluorescence and autophagy flux assays confirmed that Beclin proteins were involved in autophagy. The impacts of Beclin 1 and Beclin 2 on autophagy and tumor growth were evaluated by conversion of LC3-I to LC3-II and by clonogenic assays, respectively.
Oral cancer tissues exhibited aberrant expressions of Beclin 1 and Beclin 2. The cytoplasmic Beclin 1 and Beclin 2 expressions were unrelated in oral cancer tissues. In survival analyses, high cytoplasmic Beclin 1 expression was associated with low disease specific survival, and negative nuclear Beclin 1 expression was associated with high recurrent free survival. Patients with either high or low cytoplasmic Beclin 2 expression had significantly lower overall survival and disease specific survival rates than those with moderate expression. In oral cancer cells, overexpression of either Beclin 1 or Beclin 2 led to autophagy activation and increased clonogenic survival; knockdown of Beclin 2 impaired autophagy and increased clonogenic survival.
Our results indicated that distinct patterns of Beclin 1 and Beclin 2 were associated with aggressive clinical outcomes. Beclin 1 overexpression, as well as Beclin 2 overexpression and depletion, contributed to tumor growth. These findings suggest Beclin proteins are associated with tumorigenesis.
Beclin 1和Beclin 2是自噬相关蛋白,它们具有相似的氨基酸序列和结构域结构。Beclin 1首次建立了自噬与癌症之间的联系。然而,Beclin 2在癌症中的作用尚不清楚。本研究旨在分析Beclin 1和Beclin 2在口腔癌组织和细胞系中的表达情况,并评估它们在癌症进展中的可能作用。
我们采用免疫组织化学方法检测了195例口腔癌组织中Beclin 1和Beclin 2的表达情况。对Beclin 1和Beclin 2的预后作用进行了统计学分析。在体外,对口腔癌细胞系SAS进行了Beclin蛋白的过表达和敲低实验。免疫荧光和自噬通量分析证实Beclin蛋白参与了自噬过程。分别通过LC3-I向LC3-II的转化和克隆形成实验评估了Beclin 1和Beclin 2对自噬和肿瘤生长的影响。
口腔癌组织中Beclin 1和Beclin 2表达异常。口腔癌组织中细胞质Beclin 1和Beclin 2的表达无相关性。在生存分析中,细胞质Beclin 1高表达与疾病特异性生存率低相关,细胞核Beclin 1阴性表达与无复发生存率高相关。细胞质Beclin 2高表达或低表达的患者总生存率和疾病特异性生存率均显著低于中等表达的患者。在口腔癌细胞中,Beclin 1或Beclin 2的过表达导致自噬激活并增加克隆形成存活率;Beclin 2的敲低损害自噬并增加克隆形成存活率。
我们的结果表明,Beclin 1和Beclin 2的不同表达模式与侵袭性临床结果相关。Beclin 1的过表达以及Beclin 2的过表达和缺失均促进肿瘤生长。这些发现提示Beclin蛋白与肿瘤发生有关。